4.7 Article

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Alzheimer's disease clinical trial update 2019-2021

Joseph Pleen et al.

Summary: The review of clinical trials targeting Alzheimer's disease from 2019 to 2021 showed that the role of biomarkers is expanding, but there are still many challenges in targeting disease modification of AD. New clinical and observational trials are focusing on prevention and diverse biological processes that influence AD pathology to halt or slow clinical progression of the disease.

JOURNAL OF NEUROLOGY (2022)

Article Biotechnology & Applied Microbiology

The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics

Eric Karran et al.

Summary: Clinical trial data for drugs targeting Aβ in Alzheimer's disease suggest that reducing amyloid plaque to a low level may reveal significant clinical benefit, but there may be a time lag between plaque removal and observable clinical benefit. The speed of amyloid removal from the brain by a potential therapy will be crucial in demonstrating clinical benefit in a clinical trial setting.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Chemistry, Medicinal

Dual Reversible Coumarin Inhibitors Mutually Bound to Monoamine Oxidase B and Acetylcholinesterase Crystal Structures

Fredrik Ekstrom et al.

Summary: Multitarget directed ligands (MTDLs) are a promising approach to tackle the complexity of multifactorial pathologies. In the treatment of Alzheimer's disease, the synergistic inhibition of monoamine oxidase B (MAO B) and acetylcholinesterase (AChE) is believed to have a potentiated effect. Compound 1 showed tight-binding inhibition of MAO B and shape complementarity with the AChE enzymatic gorge, providing structural templates for the development of dual MAO B and AChE inhibitors.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Biochemistry & Molecular Biology

Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress

Nicole G. Rummel et al.

Summary: Alzheimer's disease is common among the aging population, but aging does not necessarily lead to neurodegeneration and memory decline. Recent research focuses on metabolic changes in the AD brain related to oxidative stress, with potential intervention targets identified. The main issue in AD is an imbalance of oxidative stress, particularly within the central nervous system, leading to disruptions in metabolic processes and cell damage. Understanding the role of reactive oxygen species in these alterations can potentially lead to therapeutic options for slowing the progression of AD.

ANTIOXIDANTS & REDOX SIGNALING (2022)

Article Chemistry, Medicinal

From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series

Anze Meden et al.

Summary: The lead optimization of a series of tryptophan-based nanomolar BChE inhibitors resulted in highly potent, achiral, sp(3)-rich tertiary amines with better synthetic accessibility and high selectivity. Introduction of a carbamate warhead allowed conversion to pseudoirreversible inhibitors that covalently bound to BChE. The discovery of a novel leaving group chemotype and the structural analysis provided valuable insights for future optimization of this series.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's Disease

Jose M. Alonso et al.

Summary: The article discusses the relationship between cerebrovascular diseases and dementia caused by Alzheimer's disease, highlighting the importance of developing new dual therapeutic agents. A new small quinolylnitrone, MC903, is proposed as a potential dual therapy for stroke and Alzheimer's disease.

PHARMACEUTICALS (2021)

Review Biochemistry & Molecular Biology

Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry

Pratibha Yadav et al.

Summary: Quinoline is a versatile pharmacophore with a wide range of pharmacological activities, and quinoline hybrids have shown promising anticancer, anti-inflammatory, antibacterial, and other activities. Numerous studies have summarized the recent advances of quinoline derivatives, helping in the development of clinically viable drug candidates for the treatment of incurable diseases.

BIOORGANIC CHEMISTRY (2021)

Article Neurosciences

The Ontogeny of Hippocampus-Dependent Memories

Flavio Donato et al.

Summary: This article discusses the development and biological correlates of hippocampus-dependent memories during infancy, highlighting that despite the immature circuitry of the infant hippocampus, it is still capable of forming lasting memories.

JOURNAL OF NEUROSCIENCE (2021)

Article Chemistry, Medicinal

Novel Antimicrobial 8-Hydroxyquinoline-Based Agents: Current Development, Structure-Activity Relationships, and Perspectives

Angelica Rocha Joaquim et al.

Summary: The search for new antimicrobials is crucial due to emerging resistance, and revisiting known classes like 8-hydroxyquinolines could be an interesting strategy. However, the underuse of drugs like nitroxoline and clioquinol, limited availability in few countries, has hindered their full potential.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry

Rohini Gupta et al.

Summary: 8-Hydroxyquinoline is an important heterocyclic scaffold in organic and analytical chemistry, used for detecting metal ions and anions due to its chromophore properties. Recently, synthetic modification of 8-hydroxyquinoline has garnered attention for developing potent drug molecules for the treatment of diseases like cancer, HIV, and neurodegenerative disorders. The metal chelation properties of 8-hydroxyquinoline and its derivatives also make them potential drug candidates for various diseases.

BIOORGANIC CHEMISTRY (2021)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Review Biochemistry & Molecular Biology

Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives

Kehinde D. Fasae et al.

Summary: Alzheimer's disease is the leading cause of cognitive impairment and dementia globally, with various hypotheses on its pathobiology but no confirmed diagnostics or approved cure. Studies suggest that imbalances in biometal ions and metal-amyloid interactions play crucial roles in AD pathogenesis, highlighting the importance of therapeutic chelation strategies in reducing cerebral metal burden and inhibiting A beta aggregation. Developments in multi-target ligands as potential anti-AD drug candidates show promise in addressing the limitations of current drug candidates and improving chelation-based therapeutics for AD.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2021)

Review Medicine, General & Internal

Parkinson's disease

Bastiaan R. Bloem et al.

Summary: Parkinson's disease is a neurodegenerative condition with diverse causes and clinical presentations. Diagnosis is clinically based, and treatment goals vary from person to person, emphasizing the need for personalized management. Currently, there is no therapy to slow down or arrest the progression of Parkinson's disease.

LANCET (2021)

Article Biochemistry & Molecular Biology

Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis

Hyun-U Cho et al.

Summary: Traditional belief holds that both MAO-A and MAO-B are involved in dopamine degradation, but recent research shows that MAO-A mainly affects dopamine degradation while MAO-B is responsible for mediating GABA synthesis.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders

Danielle N. Jones et al.

Summary: This review provides an overview of our current understanding of monoamine oxidases and their roles in neuropsychiatric, neurodevelopmental, and neurodegenerative diseases. It highlights important species differences in the function and development of monoamine oxidases in the brain, as well as sex-specific regulatory mechanisms and their implications for various neurological disorders. While our knowledge of monoamine oxidases has expanded, there are still gaps in understanding sex and species differences and their roles in conditions commonly comorbid with neurological disorders.

JOURNAL OF CHEMICAL NEUROANATOMY (2021)

Review Endocrinology & Metabolism

Role of metals in Alzheimer's disease

Nikita Das et al.

Summary: Metal homeostasis in the central nervous system is crucial for healthy brain function, with imbalances leading to neural network disruption and cognitive deficits. Understanding the role of metals in neurodegenerative pathology may pave the way for novel therapies against diseases like Alzheimer's. The use of metal chelating agents shows potential in ameliorating Alzheimer's Disease, but further research into neurodegenerative etiology is necessary to develop more effective treatments.

METABOLIC BRAIN DISEASE (2021)

Article Clinical Neurology

Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019

David S. Knopman et al.

Summary: Aducanumab recently underwent two large phase III clinical trials that were stopped prematurely by the sponsor due to divergent outcomes. One trial showed potential benefits from high doses of Aducanumab, while the other did not show any benefits. Further analysis is needed to determine the true efficacy as a treatment for Alzheimer's disease.

ALZHEIMERS & DEMENTIA (2021)

Review Chemistry, Medicinal

Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy

Maria do Carmo Carreiras et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Review Medicine, General & Internal

Diagnosis and Treatment of Parkinson Disease A Review

Melissa J. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Biochemistry & Molecular Biology

Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy

Agnieszka Zagorska et al.

MOLECULES (2020)

Article Chemistry, Medicinal

Recent Advances on Nitrones Design for Stroke Treatment

Jose Marco-Contelles

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors

Anze Meden et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Chemistry, Medicinal

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review

Shoaib Manzoor et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Sequential formation of different layers of dystrophic neurites in Alzheimer's brains

Md Golam Sharoar et al.

MOLECULAR PSYCHIATRY (2019)

Article Chemistry, Medicinal

Harnessing Polypharmacology with Medicinal Chemistry

Maria Laura Bolognesi

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Article Chemistry, Medicinal

Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents

Catarina Oliveira et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands

Diego Alejandro Rodriguez-Soacha et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemical Research Methods

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

Dorothee Liebschner et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)

Review Medicine, General & Internal

Diagnosis and Management of Dementia: Review

Zoe Arvanitakis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Review Biochemistry & Molecular Biology

Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer's Disease

Huan Wang et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Editorial Material Biochemistry & Molecular Biology

Alzheimer's Disease, the One-Molecule, One-Target Paradigm, and the Multitarget Directed Ligand Approach

Maria Jesus Oset-Gasque et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Review Geriatrics & Gerontology

Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals

Soghra Bagheri et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Review Clinical Neurology

Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases

Moussa B. H. Youdim

JOURNAL OF NEURAL TRANSMISSION (2018)

Review Chemistry, Medicinal

Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment

Julien Lalut et al.

FUTURE MEDICINAL CHEMISTRY (2017)

Article Neurosciences

Neuron-Astrocyte Signaling is Preserved in the Aging Brain

Marta Gomez-Gonzalo et al.

Article Multidisciplinary Sciences

Novel Object Recognition Test for the Investigation of Learning and Memory in Mice

Lindsay M. Lueptow

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)

Article Biochemical Research Methods

Polder maps: improving OMIT maps by excluding bulk solvent

Dorothee Liebschner et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)

Article Chemistry, Multidisciplinary

Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases

Oscar M. Bautista-Aguilera et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)

Review Chemistry, Medicinal

Designing Irreversible InhibitorsWorth the Effort?

Concepcion Gonzalez-Bello

CHEMMEDCHEM (2016)

Review Medicine, Research & Experimental

Experimental models of Alzheimer's disease for deciphering the pathogenesis and therapeutic screening (Review)

Xueyuan Li et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)

Article Geriatrics & Gerontology

Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice

Huang Huang et al.

Article Chemistry, Medicinal

Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation

Ming-Yu Wu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Multidisciplinary Sciences

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease

Jeff Sevigny et al.

NATURE (2016)

Review Neurosciences

Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration

Rona R. Ramsay et al.

FRONTIERS IN NEUROSCIENCE (2016)

Article Multidisciplinary Sciences

Development of an in-vivo active reversible butyrylcholinesterase inhibitor

Urban Kosak et al.

SCIENTIFIC REPORTS (2016)

Article Biochemical Research Methods

FEM: feature-enhanced map

Pavel V. Afonine et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)

Article Biochemistry & Molecular Biology

GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease

Seonmi Jo et al.

NATURE MEDICINE (2014)

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

Article Biochemistry & Molecular Biology

Probing the Peripheral Site of Human Butyrylcholinesterase

Ian R. Macdonald et al.

BIOCHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure

Xavier Brazzolotto et al.

FEBS JOURNAL (2012)

Review Psychology, Experimental

The novel object recognition memory: neurobiology, test procedure, and its modifications

M. Antunes et al.

COGNITIVE PROCESSING (2012)

Article Biochemical Research Methods

Data processing and analysis with the autoPROC toolbox

Clemens Vonrhein et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Article Biochemical Research Methods

REFMAC5 for the refinement of macromolecular crystal structures

Garib N. Murshudov et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Article Biochemical Research Methods

Overview of the CCP4 suite and current developments

Martyn D. Winn et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Review Behavioral Sciences

The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies

Inge Klinkenberg et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)

Article Chemistry, Organic

Facile Synthesis of 1-Hydroxy-5-methoxy-Benzo[f][2,7]naphthyridines

P. V. Rajeev et al.

SYNTHETIC COMMUNICATIONS (2010)

Article Biochemical Research Methods

electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation

Nigel W. Moriarty et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)

Editorial Material Biochemical Research Methods

Application of the Van Slyke-Cullen irreversible mechanism in the analysis of enzymatic progress curves

Petr Kuzmic

ANALYTICAL BIOCHEMISTRY (2009)

Article Chemistry, Applied

DPPH antioxidant assay revisited

Om P. Sharma et al.

FOOD CHEMISTRY (2009)

Article Instruments & Instrumentation

EDNA: a framework for plugin-based applications applied to X-ray experiment online data analysis

Marie-Francoise Incardona et al.

JOURNAL OF SYNCHROTRON RADIATION (2009)

Review Chemistry, Medicinal

Multi-target-directed ligands to combat neurodegenerative diseases

Andrea Cavalli et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Rebecca Radde et al.

EMBO REPORTS (2006)

Article Biochemistry & Molecular Biology

Structural insights into substrate traffic and inhibition in acetylcholinesterase

Jacques-Philippe Colletier et al.

EMBO JOURNAL (2006)

Article Chemistry, Medicinal

QSAR for acetylcholinesterase and butyrylcholinesterase inhibition by cardiovascular drugs and benzodiazepines

Shyh-Ying Chiou et al.

MEDICINAL CHEMISTRY RESEARCH (2005)

Article Chemistry, Analytical

Data analysis in the determination of stoichiometries and stability constants of complexes

JM Bosque-Sendra et al.

ANALYTICAL SCIENCES (2003)

Article Instruments & Instrumentation

An overview of the CCP4 project in protein crystallography: an example of a collaborative project

MD Winn

JOURNAL OF SYNCHROTRON RADIATION (2003)

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of MAO-A selective 1,4-disubstituted-1,2,3,6-tetrahydropyridinyl substrates

P Bissel et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2002)

Article Biochemical Research Methods

High-level expression of human liver monoamine oxidase B in Pichia pastoris

P Newton-Vinson et al.

PROTEIN EXPRESSION AND PURIFICATION (2000)

Article Biochemistry & Molecular Biology

Atypical effect of some spin trapping agents: Reversible inhibition of acetylcholinesterase

D Milatovic et al.

FREE RADICAL BIOLOGY AND MEDICINE (2000)